tiprankstipranks
Advertisement
Advertisement
Traws Pharma announces antiviral program targeting Hantavirus, Ebola
PremiumThe FlyTraws Pharma announces antiviral program targeting Hantavirus, Ebola
21d ago
Traws Pharma Updates ATM Equity Offering Prospectus Supplements
Premium
Company Announcements
Traws Pharma Updates ATM Equity Offering Prospectus Supplements
22d ago
Traws Pharma Highlights Q1 Results and Antiviral Pipeline Progress
Premium
Company Announcements
Traws Pharma Highlights Q1 Results and Antiviral Pipeline Progress
1M ago
Traws Pharma Delays 10-K Amid Financing Review
PremiumCompany AnnouncementsTraws Pharma Delays 10-K Amid Financing Review
3M ago
Traws Pharma Highlights Positive Ratutrelvir Phase 2 COVID-19 Data
Premium
Company Announcements
Traws Pharma Highlights Positive Ratutrelvir Phase 2 COVID-19 Data
4M ago
Traws Pharma completes clinical analysis of Phase 2 study of ratutrelvir
Premium
The Fly
Traws Pharma completes clinical analysis of Phase 2 study of ratutrelvir
4M ago
Traws Pharma advances flu and COVID-19 antiviral pipeline
PremiumCompany AnnouncementsTraws Pharma advances flu and COVID-19 antiviral pipeline
5M ago
Traws Pharma files tivoxavir marboxil IND application with U.S. FDA
Premium
The Fly
Traws Pharma files tivoxavir marboxil IND application with U.S. FDA
5M ago
Promising Phase 2 Results for Ratutrelvir Highlight Clinical and Market Differentiation in COVID-19 Treatment
Premium
Ratings
Promising Phase 2 Results for Ratutrelvir Highlight Clinical and Market Differentiation in COVID-19 Treatment
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100